Scientific and clinical implications of genetic and cellular heterogeneity in uveal melanoma

by Mark J. de Lange, Rogier J. Nell, Pieter A. van der Velden
Published 2021-08-01

Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.

by Mieke Versluis, Mark J de Lange, Sake I van Pelt, Claudia A L Ruivenkamp, Wilma G M Kroes, Jinfeng Cao, Martine J Jager, Gre P M Luyten, Pieter A van der Velden
Published 2015-01-01

Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism.

by Mark J de Lange, Lubna Razzaq, Mieke Versluis, Sven Verlinde, Mehmet Dogrusöz, Stefan Böhringer, Marina Marinkovic, Gregorius P M Luyten, Rob J W de Keizer, Frank R de Gruijl, Martine J Jager, Pieter A van der Velden
Published 2015-01-01